Articles:

Y Chern, JY Chiou, HL Lai, and MH Tsai

Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A
Mol Pharmacol 1995 48: 1-8. [Abstract] [PDF]  

G Weng, F Yee, P Michl, D Reis, and C Wahlestedt

Studies on neuropeptide Y receptors in a mouse adrenocortical cell line
Mol Pharmacol 1995 48: 9-14. [Abstract] [PDF]  

HJ Prochaska, WG Bornmann, P Baron, and B Polsky

Inhibition of human immunodeficiency virus type 1 replication by 7- methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz
Mol Pharmacol 1995 48: 15-20. [Abstract] [PDF]  

C Borchers, WR Ulrich, K Klemm, W Ise, V Gekeler, S Haas, A Schodl, J Conrad, M Przybylski, and R Boer

B9209-005, an azido derivative of the chemosensitizer dexniguldipine- HCl, photolabels P-glycoprotein
Mol Pharmacol 1995 48: 21-29. [Abstract] [PDF]  

P De Isabella, M Palumbo, C Sissi, G Capranico, N Carenini, E Menta, A Oliva, S Spinelli, AP Krapcho, and FC Giuliani

Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide- anthracenedione derivatives
Mol Pharmacol 1995 48: 30-38. [Abstract] [PDF]  

CC Chen, J Chang, and WC Chen

Role of protein kinase C subtypes alpha and delta in the regulation of bradykinin-stimulated phosphoinositide breakdown in astrocytes
Mol Pharmacol 1995 48: 39-47. [Abstract] [PDF]  

RE Link, MS Stevens, M Kulatunga, M Scheinin, GS Barsh, and BK Kobilka

Targeted inactivation of the gene encoding the mouse alpha 2c- adrenoceptor homolog
Mol Pharmacol 1995 48: 48-55. [Abstract] [PDF]  

S Cavallaro, V D'Agata, V Guardabasso, S Travali, F Stivala, and PL Canonico

Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells
Mol Pharmacol 1995 48: 56-62. [Abstract] [PDF]  

JF Margiotta and D Pardi

Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity
Mol Pharmacol 1995 48: 63-71. [Abstract] [PDF]  

RT Reilly, KW Barbour, RB Dunlap, and FG Berger

Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase
Mol Pharmacol 1995 48: 72-79. [Abstract] [PDF]  

PA Jr Glascott, E Gilfor, and JL Farber

Relationship of the metabolism of vitamins C and E in cultured hepatocytes treated with tert-butyl hydroperoxide
Mol Pharmacol 1995 48: 80-88. [Abstract] [PDF]  

B Rehberg, E Bennett, YH Xiao, SR Levinson, and DS Duch

Voltage- and frequency-dependent pentobarbital suppression of brain and muscle sodium channels expressed in a mammalian cell line
Mol Pharmacol 1995 48: 89-97. [Abstract] [PDF]  

RJ Hill, AM Grant, W Volberg, L Rapp, C Faltynek, D Miller, K Pagani, E Baizman, S Wang, and JW Guiles

WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes
Mol Pharmacol 1995 48: 98-104. [Abstract] [PDF]  

DR Groebe, JM Dumm, ES Levitan, and SN Abramson

alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors
Mol Pharmacol 1995 48: 105-111. [Abstract] [PDF]  

LM Winn and PG Wells

Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity
Mol Pharmacol 1995 48: 112-120. [Abstract] [PDF]  

PF Mery, C Pavoine, F Pecker, and R Fischmeister

Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes
Mol Pharmacol 1995 48: 121-130. [Abstract] [PDF]  

TM Piser, RA Lampe, RA Keith, and SA Thayer

Omega-grammotoxin SIA blocks multiple, voltage-gated, Ca2+ channel subtypes in cultured rat hippocampal neurons
Mol Pharmacol 1995 48: 131-139. [Abstract] [PDF]  

PA Johansen, LA Chase, AD Sinor, JF Koerner, RL Johnson, and MB Robinson

Type 4a metabotropic glutamate receptor: identification of new potent agonists and differentiation from the L-(+)-2-amino-4-phosphonobutanoic acid-sensitive receptor in the lateral perforant pathway in rats
Mol Pharmacol 1995 48: 140-149. [Abstract] [PDF]  

J Labrecque, A Fargin, M Bouvier, P Chidiac, and M Dennis

Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells
Mol Pharmacol 1995 48: 150-159. [Abstract] [PDF]  

JA Yao, NC Saxena, MR Ziai, S Ling, and GN Tseng

Effects of n-dodecylguanidine on A-type potassium channels: role of external surface charges in channel gating
Mol Pharmacol 1995 48: 160-171. [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.